Home › Arrhythmia › California › San Francisco
Arrhythmia clinical trials in San Francisco, CA
5 studies for Arrhythmia are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of A Clinical Diagnostic Test for CRDS
Recruiting
- University of California, San Francisco
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RecruitingPhase 4
- University of California San Francisco, San Francisco
A Phase 2 Study of CRD-4730 in CPVT
RecruitingPhase 2
- Cardurion Investigative Site, San Francisco
Developing a Digital Aid to Improve ICD Decisions
Recruiting
- University of California, San Francisco, San Francisco
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
RecruitingObservational study
- UCSF, San Francisco
About Arrhythmia
If you have an arrhythmia, or irregular heartbeat, your heart may beat too quickly, too slowly, or with an irregular rhythm. Learn about causes and treatments.
More about Arrhythmia on MedlinePlus
Arrhythmia trials in other cities
- New York City, NY8 studies
- Rochester, MN7 studies
- Cleveland, OH5 studies
- Philadelphia, PA5 studies
- Mountain View, CA5 studies
- Austin, TX5 studies
- Indianapolis, IN4 studies
- Houston, TX4 studies
- Washington, DC4 studies
- Boston, MA4 studies
- Santa Clarita, CA4 studies
- Chicago, IL3 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.